PKBO vs. IGNY, SQZ, AMPE, SIENQ, ATHX, CALA, SCPS, SMFL, MOTS, and ADTX
Should you be buying Peak Bio stock or one of its competitors? The main competitors of Peak Bio include Ignyte Acquisition (IGNY), SQZ Biotechnologies (SQZ), Ampio Pharmaceuticals (AMPE), Sientra (SIENQ), Athersys (ATHX), Calithera Biosciences (CALA), Scopus BioPharma (SCPS), Smart for Life (SMFL), Motus GI (MOTS), and Aditxt (ADTX). These companies are all part of the "medical" sector.
Peak Bio (NASDAQ:PKBO) and Ignyte Acquisition (NASDAQ:IGNY) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, community ranking, risk, institutional ownership and valuation.
In the previous week, Peak Bio's average media sentiment score of 0.00 equaled Ignyte Acquisition'saverage media sentiment score.
Peak Bio received 1 more outperform votes than Ignyte Acquisition when rated by MarketBeat users.
61.1% of Ignyte Acquisition shares are owned by institutional investors. 19.9% of Peak Bio shares are owned by insiders. Comparatively, 19.9% of Ignyte Acquisition shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Peak Bio has a beta of 0.12, meaning that its stock price is 88% less volatile than the S&P 500. Comparatively, Ignyte Acquisition has a beta of 0.19, meaning that its stock price is 81% less volatile than the S&P 500.
Ignyte Acquisition has lower revenue, but higher earnings than Peak Bio.
Ignyte Acquisition's return on equity of 365.46% beat Peak Bio's return on equity.
Summary
Ignyte Acquisition beats Peak Bio on 4 of the 7 factors compared between the two stocks.
Get Peak Bio News Delivered to You Automatically
Sign up to receive the latest news and ratings for PKBO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PKBO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Peak Bio Competitors List
Related Companies and Tools
